T

Tellus Therapeutics, Inc

8 employees

Tellus Therapeutics develops novel small molecules derived from human maternal breast milk.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
neonatology
brain injury
white matter injury

Date founded

2018

Funding rounds raised

Total raised

$35M

from 3 investors over 3 rounds

T

Tellus Therapeutics, Inc raised $35M on December 13, 2022

Investors: Xontogeny

T

Tellus Therapeutics, Inc raised $2M on May 12, 2021

Investors: Xontogeny

T

Tellus Therapeutics, Inc raised $250K on May 6, 2020

Investors: North Carolina Biotechnology Center (NCBiotech)

FAQ